Population pharmacodynamic analysis of LDL-cholesterol lowering effects by statins and co-medications based on electronic medical records

AIMS: HMG-CoA reductase inhibitors are available for use in low density lipoprotein-cholesterol (LDL-C) lowering therapy. The purposes of this study were to develop a population pharmacodynamic (PPD) model to describe the time course for the LDL-C lowering effects of statins and assess the efficacy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Clin Pharmacol
Main Authors: Kakara, Makoto, Nomura, Hiroko, Fukae, Masato, Gotanda, Keisuke, Hirota, Takeshi, Matsubayashi, Sunao, Shimomura, Hideki, Hirakawa, Masaaki, Ieiri, Ichiro
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Pharmacodynamics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4239976/
https://ncbi.nlm.nih.gov/pubmed/24734885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12405
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados